Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Oxford BioDynamics ( (GB:OBD) ) is now available.
Unicorn Asset Management Limited has significantly reduced its holdings in Oxford BioDynamics, as indicated by the notification of major holdings. The voting rights percentage held by Unicorn Asset Management decreased from 23% to 7.41%, signaling a major shift in shareholder composition. This change could impact the company’s market dynamics and investor relations.
More about Oxford BioDynamics
Oxford BioDynamics is a biotechnology company focused on developing and commercializing molecular diagnostic products. The company is known for its expertise in epigenetic biomarkers and aims to enhance personalized medicine through its innovative solutions.
YTD Price Performance: -66.67%
Average Trading Volume: 3,491,952
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.76M
For a thorough assessment of OBD stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue